HERNANDEZ-SANCHEZ, M., Jana KOTAŠKOVÁ, A.E. RODRIGUEZ, Lenka RADOVÁ, D. TAMBORERO, M. ABAIGAR, Karla PLEVOVÁ, R. BENITO, Nikola TOM, M. QUIJADA-ALAMO, Vasileios BIKOS, A.A. MARTIN, Karol PÁL, A. DE COCA, Michael DOUBEK, N. LOPEZ-BIGAS, J.M. HERNANDEZ-RIVAS and Šárka POSPÍŠILOVÁ. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase (CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.). Online. Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 2, p. 518-522. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0255-1. [citováno 2024-04-23]
Other formats:   BibTeX LaTeX RIS
Basic information
Original name CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Authors HERNANDEZ-SANCHEZ, M. (724 Spain), Jana KOTAŠKOVÁ (203 Czech Republic, belonging to the institution), A.E. RODRIGUEZ (724 Spain), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), D. TAMBORERO (724 Spain), M. ABAIGAR (724 Spain), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), R. BENITO (724 Spain), Nikola TOM (203 Czech Republic, belonging to the institution), M. QUIJADA-ALAMO (724 Spain), Vasileios BIKOS (300 Greece, belonging to the institution), A.A. MARTIN (724 Spain), Karol PÁL (703 Slovakia, belonging to the institution), A. DE COCA (724 Spain), Michael DOUBEK (203 Czech Republic, belonging to the institution), N. LOPEZ-BIGAS (724 Spain), J.M. HERNANDEZ-RIVAS (724 Spain) and Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition Leukemia, London, Nature Publishing Group, 2019, 0887-6924.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.665
RIV identification code RIV/00216224:14740/19:00109079
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1038/s41375-018-0255-1
UT WoS 000457857300023
Keywords in English CLL - genetic aberrations - NGS - WES
Tags 14110212, CF GEN, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 9/3/2020 19:40.
Abstract
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
Links
EF16_013/0001634, research and development projectName: Národní centrum lékařské genomiky - modernizace infrastruktury a výzkum genetické variability populace
LM2015091, research and development projectName: Národní centrum lékařské genomiky (Acronym: NCLG)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/0968/2017, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A
7E13008, research and development projectName: Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 23/4/2024 17:59